• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant

tetano

Editor, Senior Moderator
J Med Virol


. 2022 Jan 5.
doi: 10.1002/jmv.27575. Online ahead of print.
Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant


Giuseppe Lippi[SUP] 1 [/SUP], Camilla Mattiuzzi[SUP] 2 [/SUP], Brandon M Henry[SUP] 3 4 [/SUP]



Affiliations

Abstract

The recent emergence of a new variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) called Omicron (B.1.1.529) has raised paramount concerns in scientific and medical communities due to the presence of several mutations in the spike protein, many of which are located within the receptor binding domain (RBD).[SUP]1[/SUP] Some of these mutations were found to have a substantial influence on host cells receptor and anti-SARS-CoV-2 antibodies binding,[SUP]2[/SUP] which may then impact infectivity and neutralizing antibodies escape, thus potentially magnifying the risk of COVID-19 (coronavirus disease 2019) vaccine breakthrough. We have hence carried out a scientific literature search, aimed at summarizing the currently published evidence on Omicron variant neutralizing properties of serum or plasma collected from recipients of COVID-19 vaccines.

Keywords: COVID-19; Neutralization; Omicron; SARS-CoV-2; Variants.
 
Back
Top Bottom